- For the University
- For external organisations
- Contact us
Cambridge Enterprise portfolio company Sphere Fluidics has been named one of the UK's top 50 disruptive SMEs by Real Business.
The award was bestowed during the fourth annual Everline Future 50 competition in which organisers search the UK business landscape for companies that are ‘breaking down barriers, creating innovative products and – most importantly – disrupting previously stagnant industries.’
Sphere Fluidics, which is commercialising lab-on-a-chip and picodroplet technology developed at the University of Cambridge, based on the research of Professors Chris Abell and Wilhelm Huck of the Department of Chemistry, has created unique products for use in single cell analysis and characterisation and also provides collaborative R&D services in this area.
It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary.Dr Rob Marchmont
Dr Rob Marchmont, Fluidic’s Commerical Director, attended the awards ceremony and stated “It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary.”